#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Bruce Halpryn Email
How to contact Bruce Halpryn
Join and see Bruce's contact info for free!Current Roles
Employees:
10Revenue:
$775kAbout
Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment. It has recently been discovered that certain pathological cells – but not healthy cells – including cancers with high unmet need and high mortality such as triple-negative breast cancer, ovarian cancer, metastatic melanoma, and a broad range of other solid tumors, express tissue factor on the surface of their cell membranes. Several other non-cancerous indications such as endometriosis also highly and selectively express tissue factor.Eikonoklastes Therapeutics Address
2356 Park Avenull, null